Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer now shows revision v3.7.2 instead of v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T10:43:20.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 error page, with its footer revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T11:22:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access is blocked; the new markup reflects an error state rather than the typical study information on the page.
    Difference
    20%
    Check dated 2026-09-20T03:55:35.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now includes an explicit note of the 2016 U.S. NIH Grant/Contract funding, and the revision tag has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T23:39:10.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.5) replacing the previous v3.6.4, indicating an update to the site’s revision history rather than changes to trial content.
    Difference
    0.0%
    Check dated 2026-08-08T20:50:19.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The location entries for Zaporizhzhia in Ukraine have been updated to Zaporizhzhya with postal codes 69035 and 69600, adding two entries and removing the previous Zaporizhzhia spellings for those codes to reflect a standardized city name.
    Difference
    0.1%
    Check dated 2026-08-01T18:39:07.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.